— Know what they know.
Not Investment Advice
Also trades as: GMAB.CO (CPH) · $vol 55M · GNMSF (OTC) · $vol 1M · GE9.F (FSX) · $vol 0M

GMAB Smart Money

Genmab A/S
1W: +14.3% 1M: +26.3% 3M: +56.6% YTD: +40.4% 1Y: +49.5% 3Y: +49.7% 5Y: -1.4%
$44.67
-0.01 (-0.03%)
 
Weekly Expected Move ±8.1%
$37 $40 $44 $47 $51
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 70 · $27.5B mcap · 587M float · 0.495% daily turnover · Short 61% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 16.1% of company value Bonds: $301.5M held by 241 funds, 181 bp over Treasuries → details ▾
If the stock fell to about $0.65 (down 99%), Genmab A/S would be worth roughly what it owes.
Total debt $5.27B against a stock market value of $27.47B.
Distance to default 7.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

🏦 Institutional Activity

Latest: Q2 2026
325
Institutions Holding
-9 vs prior
10.2%
Ownership
+2.10%
51 New
102 Increased
131 Reduced
30 Closed

👔 Insider Trades

0 records
Date Name Title Type Shares Price Value Filing
No insider trades found

🏛️ Congressional Trades

17 records
Date Politician Chamber Type Amount Filing
2025-01-16 Josh Gottheimer House Buy $1,001 - $15,000 Filing
2025-01-15 Josh S. Gottheimer House Buy $1,001 - $15,000 Filing
2024-12-16 Josh Gottheimer House Sell $1,001 - $15,000 Filing
2024-07-19 Josh Gottheimer House Buy $1,001 - $15,000 Filing
2024-06-18 Josh Gottheimer House Sell $1,001 - $15,000 Filing
2023-10-16 Josh Gottheimer House Buy $1,001 - $15,000 Filing
2023-09-15 Josh Gottheimer House Sell $1,001 - $15,000 Filing
2023-07-20 Josh Gottheimer House Buy $1,001 - $15,000 Filing
2023-07-19 Josh Gottheimer House Buy $1,001 - $15,000 Filing
2023-07-10 Daniel Goldman House Sell $50,001 - $100,000 Filing
2023-03-31 Daniel Goldman House Sell $1,001 - $15,000 Filing
2020-11-20 Thomas R. Carper Senate Buy $1,001 - $15,000 Filing
2020-11-20 Thomas R. Carper Senate Buy $1,001 - $15,000 Filing
2020-11-20 Thomas R. Carper Senate Buy $1,001 - $15,000 Filing
2020-11-20 Thomas R. Carper Senate Buy $1,001 - $15,000 Filing
2020-11-20 Thomas Richard Carper Senate Buy $1,001 - $15,000 Filing
2020-11-20 Thomas Richard Carper Senate Buy $1,001 - $15,000 Filing

🏦 Top Institutional Holders

20 holders
Holder Shares Value Date Reported Filing
Paradigm Biocapital Advisors LP 13,133,131 $361M +5,165,295 2026-06-30 Filing
Orbis Allan Gray Ltd 11,368,161 $312M -1,557,417 2026-06-30 Filing
ALLIANCEBERNSTEIN L.P. 8,644,877 $232M -912,272 2026-06-30 Filing
DEERFIELD MANAGEMENT COMPANY, L.P. 6,865,000 $189M +4,403,000 2026-06-30 Filing
Deep Track Capital, LP 5,650,000 $155M +1,986,750 2026-06-30 Filing
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 4,975,324 $137M — 2026-06-30 Filing
BlackRock, Inc. 4,671,252 $128M +134,687 2026-06-30 Filing
Sofinnova Investments, Inc. 4,045,215 $111M +3,292,954 2026-06-30 Filing
RENAISSANCE TECHNOLOGIES LLC 3,517,850 $97M -896,700 2026-06-30 Filing
TWO SIGMA INVESTMENTS, LP 3,506,843 $96M +1,167,411 2026-06-30 Filing
Harding Loevner LP 3,086,318 $87M -145,283 2026-06-30 Filing
FIRST TRUST ADVISORS LP 2,756,522 $76M +295,180 2026-06-30 Filing
CITADEL ADVISORS LLC 2,475,991 $68M +2,475,991 2026-06-30 Filing
Qube Research & Technologies Ltd 1,689,284 $46M +1,011,938 2026-06-30 Filing
MORGAN STANLEY 1,630,161 $45M -554,540 2026-06-30 Filing
FEDERATED HERMES, INC. 1,449,376 $40M +197,786 2026-06-30 Filing
GOLDMAN SACHS GROUP INC 1,279,231 $35M +347,972 2026-06-30 Filing
FRANKLIN RESOURCES INC 1,202,923 $33M +9,778 2026-06-30 Filing
Pictet Asset Management Holding SA 1,065,927 $29M -11,544 2026-06-30 Filing
UBS Group AG 961,053 $26M +662,921 2026-06-30 Filing

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms